The Faculty and Student Scholarship section is provided as a service to the WSU College of Pharmacy and Pharmaceutical Sciences community for sharing publications, presentations, and other highly transactional types of information. Accuracy of the information presented is the responsibility of those who submitted it. Submissions are reviewed for compliance with state statutes and ethics guidelines but are not edited for spelling, grammar, or clarity. Submission for Pharmaceutical Sciences faculty and PhD students can be directed to Kami Ryplewski and submissions for Pharmacotherapy faculty and Doctor of Pharmacy students to Abby Parsons.
Faculty Scholarship
Publications
USTUR Director and Professor Sergei Tolmachev and two co-authors published, “A multi-collector ICP-MS method for quantification of plutonium, uranium, and americium in hair and nails of occupationally or medically exposed individuals. Talanta. Accepted 2023. https://doi.org/10.1016/j.talanta.2023.125607
Sergei Tolmachev and USTUR Associate Professor Maia Avtandilashvili published, “Long-term retention and distribution of highly-enriched uranium in occupationally exposed female. Radiation and Environmental Biophysics; Accepted 2023. https://doi.org/10.1007/s00411-023-01053-0
Maia Avtandilashvili and Sergei Tolmachev published, “Forty-eight-year follow-up of a female worker exposed to highly-enriched uranium via chronic and acute inhalation. Radiation and Environmental Biophysics; Accepted 2023. https://doi.org/10.1007/s00411-023-01055-y
Weiner S, Neumiller JJ. What to know about using non-insulin agents in type 1 diabetes. EndocrineToday. Posted December 7, 2023. Available at: https://www.healio.com/news/endocrinology/20231206/what-to-know-about-using-noninsulin-agents-in-type-1-diabetes
Alicic RZ, Neumiller JJ, Tuttle KR. 39 – Diabetes Mellitus: Management of Hypertension in Diabetes. In: Hypertension (4th Edition): A Companion to Braunwald’s Heart Disease. Bakris GL, Sorrentino MJ, Laffin LJ, Eds. Elsevier 2024;pp. 439-455.
LAlicic RZ, Neumiller JJ. Incretin therapies for patients with type 2 diabetes and chronic kidney disease. J Clin Med 2023;13(1):201evien TL, Baker DE. Drug Evaluation – Nalmefene (Opvee). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. November 2023.
Frenzel VC, Baker DE. Drug Evaluation – Etrasimod (Velsipity). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. November 2023.
Baker DE. Drug Evaluation – Donislecel (Lantidra). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. November 2023.
Baker DE. Drug Evaluation – Delandistrogene moxeparvovec (Elevidys). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. November 2023.
Felix GL, Baker DE. Drug Evaluation – Rozanolixizumab (Rystiggo). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. November 2023.
Baker DE. Drug Utilization Evaluation – Nalmefene (Opvee). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Clinical Drug Information, LLC. November 2023.
Levien TL, Baker DE. Drug Evaluation – Valoctocogene roxaparvovec-rvox (Roctavian). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. December 2023.
Hitt EM, Baker DE. Drug Evaluation – Somatrogon-ghla (Ngenla). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. December 2023.
Baker DE. Drug Evaluation – Pegunigalsidase alfa-iwxj (Elfabrio). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. December 2023.
Melbuer MM, Baker DE. Drug Evaluation – Lotilaner ophthalmic solution (Xdemvy). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. December 2023.
Hitt EM, Baker DE. Drug Evaluation – Zuranolone (Zurzuvae). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. December 2023.
Baker DE. Drug Utilization Evaluation – Zuranolone (Zurzuvae). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Clinical Drug Information, LLC. December 2023.
Maloney A, Baker DE. Drug Evaluation – Elranatimab-bcmm (Elrexfio). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. January 2024.
Levien TL, Baker DE. Drug Evaluation – Avacincaptad pegol (Izervay). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. January 2024.
Hitt EM, Baker DE. Drug Evaluation – Cantharidin (Ycanth). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. January 2024.
Baker DE. Drug Evaluation – Talquetamab (Talvey). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. January 2024.
Baker DE. Drug Evaluation – Quizartinib dihydrochloride (Vanflyta). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. January 2024.
Baker DE. Drug Utilization Evaluation – Cantharidin (Ycanth). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Clinical Drug Information, LLC. January 2024.
MacCamy K, Heldenbrand S, Robinson J. A Multisite, Longitudinal Study Assessing Prevalence of Depression in Student Pharmacists. Am J Pharm Educ. Published online December 1, 2023:100634-100634.
Neumiller JJ, Alicic RZ, Tuttle KR. Optimization of guideline-directed medical therapies in patients with diabetes and chronic kidney disease. Clin Kidney J. 2023;17(1):sfad285.
Service
Josh Neumiller has been elected 2024 President Elect, Health Care & Education for the American Diabetes Association (ADA) and will serve on the ADA Board of Directors effective January 1, 2024.
Josh Neumiller has been appointed Social Media Editor for the journal BMJ Open Diabetes Research & Care
Grants & Awards
Josh Neumiller (co-PI) in collaboration with Wendy St. Peter, PharmD (co-PI; University of Minnesota) was awarded a Medication Optimization Improving Human Health grant for $100,000 in support of their project titled: “Medication optimization in patients with chronic kidney disease with or without type 2 diabetes or heart failure to improve patient-centered health outcomes.”